Özkiriş Mahmut, Aydin Reha, Gencer Zeliha Kapusuz, Saydam Levent
Department of Otolaryngology, Head and Neck Surgery, Bozok University Medical Faculty, Yozgat, Turkey.
Am J Rhinol Allergy. 2014 May-Jun;28(3):e141-3. doi: 10.2500/ajra.2014.28.4028.
This study was designed to investigate the topical anesthetic efficacy of four different solutions including lidocaine spray, bupivacaine, ropivacaine, and prilocaine used in patients undergoing transnasal fiberoptic nasopharyngolaryngoscopic examination (TFL).
The study included 200 patients who underwent anterior rhinoscopy and TFL examination as a part of routine otolaryngological evaluation in our outpatient clinics. Of these, 111 were female and 89 were male patients. The mean age of the patients was 32 ± 8 years (aged between 19 and 55 years). The patients were randomly divided into five groups. Five groups received one of the local anesthetics studied in our trial (10% lidocaine, 0.5% ropivacaine, 0.25% bupivacaine, 2% prilocaine, and saline solution) in each right side of the nose for 10 minutes before TFL. Each separate examination was performed on the right side of the nasal cavity. After the examination, the patients were asked to note the intensity of the pain that they have experienced during the TFL, by using a 100-mm visual analog scale (VAS).
The mean VAS scores were 2.08 (SD, 0.62) in the lidocaine group, 2.21 (SD, 0.66) in the prilocaine group, 3.92 (SD, 0.58) in the ropivacaine group, 4.15 (SD, 0.64) in the bupivacaine group, and 6.35 (SD, 0.65) in the saline solution group. The lidocaine and prilocaine groups had significantly better VAS scores versus ropivacaine, bupivacaine, and saline solution groups (p < 0.05).
To provide ideal examination comfort and optimum patient tolerability during TFL evaluation of upper respiratory airway topical lidocaine and prilocaine applications were found to be more efficacious and effective medication for anesthesia of the intranasal mucosa compared with bupivacaine and ropivacaine solutions.
本研究旨在调查四种不同溶液(包括利多卡因喷雾剂、布比卡因、罗哌卡因和丙胺卡因)用于经鼻纤维鼻咽喉镜检查(TFL)患者时的局部麻醉效果。
本研究纳入了200例在我们门诊作为常规耳鼻喉科评估一部分接受前鼻镜检查和TFL检查的患者。其中,女性111例,男性89例。患者的平均年龄为32±8岁(年龄在19至55岁之间)。患者被随机分为五组。五组在TFL检查前10分钟,在每侧右侧鼻腔接受我们试验中研究的一种局部麻醉剂(10%利多卡因、0.5%罗哌卡因、0.25%布比卡因、2%丙胺卡因和生理盐水溶液)。每次单独检查均在鼻腔右侧进行。检查后,要求患者使用100毫米视觉模拟量表(VAS)记录他们在TFL检查期间所经历的疼痛强度。
利多卡因组的平均VAS评分为2.08(标准差,0.62),丙胺卡因组为2.21(标准差,0.66),罗哌卡因组为3.92(标准差,0.58),布比卡因组为4.15(标准差,0.64),生理盐水溶液组为6.35(标准差,0.65)。利多卡因组和丙胺卡因组的VAS评分明显优于罗哌卡因组、布比卡因组和生理盐水溶液组(p<0.05)。
为在上呼吸道TFL评估期间提供理想的检查舒适度和最佳患者耐受性,发现与布比卡因和罗哌卡因溶液相比,局部应用利多卡因和丙胺卡因是用于鼻黏膜麻醉更有效且高效的药物。